Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Inventories, Finished Goods: ¥0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600613 Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613
52 GF Score
Price ¥4.77
GF Value ¥5.42
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Shenqi Pharmaceutical Investment Management Co Inventories, Finished Goods?

Shanghai Shenqi Pharmaceutical Investment Management Co SHSE:600613 -3.05% 52 Inventories, Finished Goods is ¥0 Mil as of Mar. 2026. GuruFocus rates SHSE:600613 with a GF Score™ of 52/100 and a GF Value™ of ¥5.42 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Shanghai Shenqi Pharmaceutical Investment Management Co's quarterly finished goods increased from Sep. 2025 (¥0 Mil) to Dec. 2025 (¥145 Mil) but then declined from Dec. 2025 (¥145 Mil) to Mar. 2026 (¥0 Mil).

Shanghai Shenqi Pharmaceutical Investment Management Co's annual finished goods declined from Dec. 2023 (¥182 Mil) to Dec. 2024 (¥170 Mil) and declined from Dec. 2024 (¥170 Mil) to Dec. 2025 (¥145 Mil).

Shanghai Shenqi Pharmaceutical Investment Management Co Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Shanghai Shenqi Pharmaceutical Investment Management Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Shenqi Pharmaceutical Investment Management Co Inventories, Finished Goods Chart

Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 135.33 159.89 182.02 169.91 144.81

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 155.90 0.00 144.81 0.00
SHSE:600613
52GF Score
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Shenqi Pharmaceutical Investment Management Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ¥0 Mil mean?
Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) has a Inventories, Finished Goods of ¥0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors.
Is Shanghai Shenqi Pharmaceutical Investment Management Co's Inventories, Finished Goods too high?
Shanghai Shenqi Pharmaceutical Investment Management Co's current Inventories, Finished Goods is ¥0 Mil. Overall, Shanghai Shenqi Pharmaceutical Investment Management Co has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shenqi Pharmaceutical Investment Management Co's Inventories, Finished Goods compare to LLY and JNJ?
Shanghai Shenqi Pharmaceutical Investment Management Co's Inventories, Finished Goods of ¥0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. Shanghai Shenqi Pharmaceutical Investment Management Co's current Inventories, Finished Goods is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shenqi Pharmaceutical Investment Management Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.42, compared to a current price of ¥4.77 — trading 12% below its estimated fair value. The current Inventories, Finished Goods is ¥0 Mil. Shanghai Shenqi Pharmaceutical Investment Management Co's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613), the current Inventories, Finished Goods is ¥0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co stock appears to be undervalued. The current stock price of ¥4.77 is trading 12% below its estimated GF Value™ of ¥5.42. GuruFocus considers Shanghai Shenqi Pharmaceutical Investment Management Co to be Modestly Undervalued.

Key valuation signals for SHSE:600613:

  • Inventories, Finished Goods: ¥0 Mil
  • GF Value™: ¥5.42 vs. price of ¥4.77 (12% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Shenqi Pharmaceutical Investment Management Co Business Description

Other Exchanges 900904:China
Address 128 Weihai Road, Room 613, Changfa Building, Shanghai, CHN, 200003
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.
52GF Score

Get the complete analysis for SHSE:600613

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.77
Price
¥5.42
GF Value